Opus Genetics, Inc. (IRD): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

62.22M
Year ended 2025-12-31
+44.6%
3-year compound annual growth
+67.9%
5-year compound annual growth
2020-12-31: 4.66M2021-12-31: 14.85M2022-12-31: 20.60M2023-12-31: 21.59M2024-12-31: 26.72M2025-12-31: 62.22M62.22M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3162.22M+132.9%2026-03-12, From 2025-01-01
2024-12-3126.72M+23.7%2026-03-12, From 2024-01-01
2023-12-3121.59M+4.8%2025-03-31, From 2023-01-01
2022-12-3120.60M+38.7%2024-03-08, From 2022-01-01
2021-12-3114.85M+218.7%2023-03-30, From 2021-01-01
2020-12-314.66Mn/a2022-03-24, From 2020-01-01